Home » Psychology news » New drug therapy could improve brain function and life expectancy of ALS patients

New drug therapy could improve brain function and life expectancy of ALS patients

May 25, 2017 by

A researcher has successfully redesigned a portion of MabThera, an FDA-approved drug used to treat certain autoimmune diseases and types of cancer, into a new molecule to treat ALS, outlines a new report.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>